NurExone Biologic Inc. (TSXV:NRX)
Canada · Delayed Price · Currency is CAD 0.8500
+0.0100 (1.19%)
Sep 10, 2025, 3:59 PM EDT
NurExone Biologic Market Cap
NurExone Biologic has a market cap or net worth of CAD 69.26 million as of September 11, 2025. Its market cap has increased by 73.94% in one year.
Market Cap
69.26M
Enterprise Value
67.71M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.85
Market Cap Chart
Since June 23, 2022, NurExone Biologic's market cap has increased from 33.48M to 69.26M, an increase of 106.85%. That is a compound annual growth rate of 25.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2025 | 69.26M | 57.58% |
| Dec 31, 2024 | 43.95M | 208.80% |
| Dec 28, 2023 | 14.23M | -14.84% |
| Dec 22, 2022 | 16.71M | -50.08% |
| Jun 23, 2022 | 33.48M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curaleaf Holdings | 3.04B |
| Green Thumb Industries | 2.65B |
| Trulieve Cannabis | 2.02B |
| Sienna Senior Living | 1.69B |
| dentalcorp Holdings | 1.64B |
| Cronos Group | 1.33B |
| WELL Health Technologies | 1.20B |
| Extendicare | 1.10B |